Answers are grounded in this paper and cite their sources.
The global spread of carbapenem-resistant Enterobacteriaceae (CRE) is increasingly becoming a major challenge in clinical and public health settings. To date, the treatment for serious CRE infections remains difficult. The intelligent use of antimicrobials and effective infection control strategies is crucial to prevent further CRE spread. Early consultation with experts in the treatment of infections with multidrug-resistant organisms is valuable in patient management. This brief review will focus on the current, yet limited, treatment options for CRE infections.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: